This inventor holds 3 USPTO granted patents. Top assignees: Leland Stanford Junior University, Toyo Boseki Kabushiki Kaisha. Active years: 1998-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1998-2001
Title: Kazuhiro Kondo: Innovator in Cytomegalovirus Detection
Introduction
Kazuhiro Kondo is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of cytomegalovirus (CMV). With a total of 3 patents, Kondo's work has advanced the understanding and detection methods of this virus.
Latest Patents
Kondo's latest patents include a method of detecting cytomegalovirus (CMV) and a set of oligonucleotides, methods, and kits for amplifying and detecting CMV nucleic acids. The first patent provides methods and compositions related to CMV latent transcripts and polypeptides, which are specifically produced during latent infection. This invention includes RT-PCR-based methods and immunodiagnostic methods for detecting CMV in samples. The second patent focuses on two primers for amplifying CMV nucleic acids suitable for nucleic acid sequence-based amplification (NASBA). This method allows for easy, rapid, and specific detection of CMV with high sensitivity.
Career Highlights
Kondo has worked with prestigious institutions, including Leland Stanford Junior University and Toyo Boseki Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in medical diagnostics and virology.
Collaborations
Kondo has collaborated with notable individuals in his field, including Edward S Mocarski, Jr and Motohiro Kondo. These collaborations have likely enhanced his research and development efforts in CMV detection.
Conclusion
Kazuhiro Kondo's innovative work in the detection of cytomegalovirus has made a significant impact in the field of medical diagnostics. His patents reflect a commitment to advancing healthcare through improved detection methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile